Quadrant Capital Group LLC Cardiovascular Systems Inc Transaction History

Quadrant Capital Group LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$13.31 - $19.86 $8,425 - $12,571	-633 Reduced 21.15%	2,360 $46,000
Q4 2022 Feb 10, 2023	BUY	$12.74 - $15.12 $24,473 - $29,045	1,921 Added 179.2%	2,993 $40,000
Q3 2022 Nov 10, 2022	BUY	$12.93 - $17.17 $11,856 - $15,744	917 Added 591.61%	1,072 $15,000
Q2 2022 Aug 09, 2022	SELL	$13.53 - $23.34 $3,044 - $5,251	-225 Reduced 59.21%	155 $2,000
Q1 2022 May 06, 2022	BUY	$16.14 - $22.6 $6,133 - $8,588	380 New	380 $9,000
Q4 2021 Feb 01, 2022	SELL	$18.64 - $36.77 $6,635 - $13,090	-356 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$32.83 - $43.0 $65 - $86	-2 Reduced 0.56%	356 $12,000
Q1 2021 May 12, 2021	BUY	$37.29 - $47.19 $186 - $235	5 Added 1.42%	358 $14,000
Q4 2020 Feb 16, 2021	SELL	$34.3 - $44.09 $2,263 - $2,909	-66 Reduced 15.75%	353 $15,000
Q3 2020 Nov 13, 2020	SELL	$27.86 - $39.35 $501 - $708	-18 Reduced 4.12%	419 $16,000
Q2 2020 Aug 13, 2020	SELL	$30.3 - $42.55 $31,815 - $44,677	-1,050 Reduced 70.61%	437 $14,000
Q1 2020 May 15, 2020	SELL	$30.0 - $54.18 $4,320 - $7,801	-144 Reduced 8.83%	1,487 $53,000
Q4 2019 Feb 03, 2020	BUY	$42.29 - $52.2 $25,035 - $30,902	592 Added 56.98%	1,631 $78,000
Q2 2019 Jul 24, 2019	BUY	$33.93 - $43.66 $35,253 - $45,362	1,039 New	1,039 $44,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.